In a bid to bridge the gap between the pharma industry and academia and analyze various dimensions of the Industry-Academia interface, a two-day national seminar was organised by the National Institute of Pharmaceutical Education and Research (NIPER), Guwahati on Thursday and Friday.
The seminar titled “Development of Biologicals in India: Significance of Industry-Academia Collaboration, Regulatory Requirements, Challenges, Opportunities and Strategies” also emphasized promoting private sector investments in R&D, stimulating public-private partnership (PPP) with a special focus on the discovery of biologic drugs.
The seminar is sponsored by Pharmaceuticals Promotion and Development Scheme (PPDS) Programme, Dept. of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India.
The inaugural session was attended by Dr A Ramkishan, Deputy Drug Controller of Central Drugs Standard Control Organization (CDSCO) and Dr USN Murty, Director NIPER-Guwahati.
In his speech, Dr Ramkishan said that the seminar will open up opportunities for the students to understand the industry requirements in terms of regulatory concerns and will help them grow into successful entrepreneurs with updated knowledge.
Speaking on the same line, Dr Murty shared that NIPER-Guwahati looks forward to conducting such seminars and workshops in the future to benefit the students from the Northeast and other parts of the country.
The seminar is being attended by more than 850 students, researchers and faculty members from different institutes and universities from India and abroad, including around 400 participants from the Northeast.
The inaugural session was compeered by Dr. Krishna Undela, Asst. Professor, NIPER-Guwahati.